BL-918 is a potent activator of UNC-51-like kinase 1 (ULK1). BL-918 induces cytoprotective autophagy for Parkinson's disease treatment. BL-918 induced autophagy via the ULK complex in SH-SY5Y cells. Intriguingly, this activator displayed a cytoprotective effect on MPP+-treated SH-SY5Y cells, as well as protected against MPTP-induced motor dysfunction and loss of dopaminergic neurons by targeting ULK1-modulated autophagy in mouse models of PD. Together, these results demonstrate the therapeutic potential to target ULK1, and BL-918 may serve as a candidate drug for future PD treatment.
MedKoo Cat#: 555202
Name: BL-918
CAS#: 2101517-69-3
Chemical Formula: C23H15F8N3OS
Exact Mass: 533.0808
Molecular Weight: 533.44
Elemental Analysis: C, 51.79; H, 2.83; F, 28.49; N, 7.88; O, 3.00; S, 6.01
Solvent | mg/mL | mM | comments | |
---|---|---|---|---|
Solubility | ||||
DMF | 30.0 | 56.28 | ||
DMSO | 30.0 | 56.28 | ||
Ethanol | 30.0 | 56.28 |
The following data is based on the product molecular weight 533.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |